CRISPR-containing bacteriophages are being developed by biotechs as an alternative to antibiotics.
These viruses can kill harmful bacteria without damaging the healthy microbiome.
Read more in my News analysis for @NatureBiotech
https://t.co/CzGXpQS3m1
Thank you @NatureMedicine for emphasizing the strong equity elements of the revised @medwma Declaration of Helsinki and citing the TRUST and the San Code! https://t.co/tyU35m1f5v
Brilliant news, another high-profile adopter for the TRUST Code taking a stance against inequitable research, the Pasteur Network, alliance of 32 institutes in 25 countries across 5 continents, https://t.co/tlzL3oSByS
GLP-1 receptor agonists, which are effective for weight loss, can cause substantial muscle loss.
A Comment in @TheLancetEndo discusses the effects of GLP-1 receptor agonists on skeletal muscle mass: https://t.co/PySJT9uC7f
Health AI needs meaningful human involvement: lessons from war.
Correspondence from James M. Hillis & Kenneth Payne @KingsCollegeLon@harvardmed
https://t.co/eH7498ejZt
Rwanda’s Health Minister Dr. @nsanzimanasabin points to progress in controlling the #Marburg outbreak, assuring that measures are in place to safeguard travellers and conference attendees.
Join us for this week’s press briefing as @AfricaCDC Director General, Dr. @JeanKaseya2, and Rwanda's Minister of Health, Dr. @nsanzimanasabin, provide critical updates on the Mpox outbreak across @_AfricanUnion Member States. Dr. Nsanzimana will also highlight the Marburg outbreak in Rwanda and the urgent actions being taken to address it.
📅 Date: 03 October 2024
🕞 Time:
16:00 – 17:00 | East Africa Time (GMT+3)
15:00 – 16:00 | Southern Africa Time (GMT+2)
14:00 – 15:00 | Central Africa Countries (GMT+1)
🔗 Join virtually via Zoom: https://t.co/DgO1Vd3Mht
⭐Research highlight: Daily injection with the weight-loss drug #liraglutide was more effective than placebo (both combined with lifestyle interventions) at reducing weight in children aged 6–12 years with #obesity. @NEJM
https://t.co/TWRltPbPM2
#Mpox cases are rising across Africa, highlighting gaps in surveillance and testing. “Some countries report suspected cases, but without testing, we can’t confirm them or classify outbreaks,” said @AfricaCDC Director General Dr @JeanKaseya2. Contract tracing is another challenge: “We aim to trace 90% of contacts but have only reached around 4%, reflecting the performance of our surveillance systems."
A novel application of #ASO technology adds to the growing number of personalized therapies for rare diseases; but pathways to implementation & access are urgently needed
News & Views from Annemieke Aartsma-Rus & colleagues
@oligogirl@LUMC_Leiden@uni_tue
https://t.co/L18edxFVWD
📢Our September issue is now live, and includes a Focus on the state of DEI in computational science, highlighting experts' insights on ongoing challenges and strategies for creating a more diverse, equitable, and inclusive field for all.
➡️https://t.co/Q2wC0Ynm5z
🧵(1/11)
There is a pervasive myth that the DRC 🇨🇩 and other countries in Africa affected by the current #mpox outbreak lack capacity for the many elements that are needed for effective outbreak response.
That is not true… my piece in @statnews https://t.co/LGluakA6ag
Women account for 67% of the health and care workforce and yet they are still paid 24% less on average than men working in the sector: https://t.co/1xbcli6wQU
This needs to end. #EqualPayDay
Information on clinical trial progress of implanted brain-computer interfaces remains scarce. Join our webinar with Pepe Contreras-Vidal and Mariska Vansteensel discussing the state of clinical trials of implantable brain-computer interfaces
Register here: https://t.co/GLYmGesm8r
🆕Recordings and presentations now available from the #Mpox research and innovation organized by @WHO@rd_blueprint@CEPIvaccines@AfricaCDC@NIH
Thanks to all those who contributed to aligning research response with the outbreak goals
@DrTedros
https://t.co/7YOijJLiq3